HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,662,827 | +16.1% | 46,100 | +22.9% | 0.18% | +1.1% |
| Q1 2023 | $1,432,125 | +231.2% | 37,500 | +393.4% | 0.18% | +181.0% |
| Q4 2022 | $432,440 | -32.1% | 7,600 | -52.8% | 0.06% | -51.2% |
| Q3 2022 | $637,000 | -27.3% | 16,100 | -19.1% | 0.13% | -20.9% |
| Q2 2022 | $876,000 | +147.5% | 19,900 | +155.1% | 0.16% | +77.2% |
| Q2 2021 | $354,000 | +0.3% | 7,800 | -7.9% | 0.09% | +13.6% |
| Q1 2021 | $353,000 | -23.6% | 8,465 | -62.9% | 0.08% | -13.8% |
| Q4 2017 | $462,000 | +376.3% | 22,800 | +103.6% | 0.09% | +62.1% |
| Q2 2016 | $97,000 | – | 11,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |